ALBIREO PHARMA, INC. Chart calendar Albireo Pharma, Inc.
d5313c2e31f8e91.LsM3PeFbmTKgH-XVHTS2iXOOKcy9VGPziN9HlZ0MKT0.Yrl1Z9UOoFbaeouXbQHs6AK6BIH4LgCl0pQTpfAhRgRPogUElT7xc-R13Q~9b7f648e0f439160f1d1a75d87424b97
Upcoming events on Albireo Pharma, Inc.
No events available
Past events on Albireo Pharma, Inc.
| 2022-11-15 05:20 | Jefferies London Healthcare Conference |
| 2022-11-08 16:30 | Q3 2022 Earnings Call |
| 2022-11-07 | Q3 2022 Earnings Release After hours |
| 2022-11-07 13:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37254 |
| 2022-11-07 13:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37608 |
| 2022-11-07 13:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 850 |
| 2022-11-07 13:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37939 |
| 2022-11-07 13:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37273 |
| 2022-11-06 14:10 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 865 |
| 2022-11-06 13:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Meeting : 37733 |
| 2022-10-18 10:30 | H.C. Wainwright Hepatitis B Virus (HBV) Conference |
| 2022-10-15 14:00 | NASPGHAN Meeting |
| 2022-10-15 12:00 | NASPGHAN Meeting - Abstract Number : 547 |
| 2022-10-14 13:45 | NASPGHAN Meeting |
| 2022-10-14 12:00 | NASPGHAN Meeting - Abstract Number : 301 |
| 2022-10-13 17:00 | NASPGHAN Meeting - Abstract Number : 70 |
| 2022-10-11 08:30 | Bylvay Phase 3 Trial Results Call |
| 2022-09-28 08:30 | Guggenheim Therapeutics Conference |
| 2022-09-13 08:30 | Baird Global Healthcare Conference |
| 2022-09-12 10:30 | Morgan Stanley Global Healthcare Conference |
More events
